REED VICKIE S
Insider CIK 1405637 · EVOK Director · MRTX SVP, Chief Accounting Officer · ADMP Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| EVOK Evoke Pharma Inc | D To issuer deriv | 2025-12-17 | 2025-12-17 | 1,250 | — | $0 | 0 | SEC↗ |
| EVOK Evoke Pharma Inc | D To issuer deriv | 2025-12-17 | 2025-12-17 | 1,250 | — | $0 | 0 | SEC↗ |
| EVOK Evoke Pharma Inc | D To issuer deriv | 2025-12-17 | 2025-12-17 | 5,833 | — | $0 | 0 | SEC↗ |
| EVOK Evoke Pharma Inc | A Award deriv | 2025-05-21 | 2025-05-22 | 1,250 | — | $0 | 8,333 | SEC↗ |
| EVOK Evoke Pharma Inc | A Award deriv | 2025-01-28 | 2025-01-29 | 5,833 | — | $0 | 5,833 | SEC↗ |
| EVOK Evoke Pharma Inc | A Award deriv | 2024-05-22 | 2024-05-24 | 15,000 | — | $0 | 15,000 | SEC↗ |
| EVOK Evoke Pharma Inc | A Award deriv | 2023-05-10 | 2023-05-11 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ADMP Adamis Pharmaceuticals Cor | A Award deriv | 2022-05-24 | 2022-05-26 | 50,000 | — | $0 | 50,000 | SEC↗ |
| EVOK Evoke Pharma Inc | A Award deriv | 2022-04-27 | 2022-04-28 | 58,000 | — | $0 | 58,000 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2022-01-18 | 2022-01-18 | 533 | $120.48 | $64.2K | 15,369 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | A Award deriv | 2022-01-14 | 2022-01-18 | 8,910 | — | $0 | 8,910 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | A Award | 2022-01-14 | 2022-01-18 | 5,377 | — | $0 | 15,902 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2022-01-07 | 2022-01-07 | 345 | $135.94 | $46.9K | 10,525 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2022-01-04 | 2022-01-06 | 758 | $147.74 | $112.0K | 10,870 | SEC↗ |
| EVOK Evoke Pharma Inc | A Award deriv | 2021-05-13 | 2021-05-17 | 70,000 | — | $0 | 70,000 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | A Award deriv | 2021-01-15 | 2021-01-20 | 6,499 | — | $0 | 6,499 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | A Award | 2021-01-15 | 2021-01-20 | 4,157 | — | $0 | 11,628 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2021-01-07 | 2021-01-08 | 241 | $216.33 | $52.1K | 7,471 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2021-01-06 | 2021-01-08 | 527 | $210.28 | $110.8K | 7,712 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2021-01-06 | 2021-01-08 | 11 | $215.70 | $2.4K | 8,239 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | A Award deriv | 2020-11-02 | 2020-11-06 | 2,523 | — | $0 | 2,523 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | A Award deriv | 2020-11-02 | 2020-11-12 | 2,522 | — | $0 | 2,522 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | A Award deriv | 2020-01-06 | 2020-01-15 | 5,500 | — | $0 | 5,500 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | A Award | 2020-01-06 | 2020-01-15 | 2,750 | — | $0 | 8,250 | SEC↗ |